Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the creation of potent benzoxazepine derivatives that exhibit anxiolytic, anticonvulsant, and sedative properties. The presence of bromo and fluoro substituents enhances binding affinity to specific neuronal receptors, making it valuable in medicinal chemistry for optimizing drug potency and selectivity. Commonly employed in research settings to design novel therapeutics targeting neurological disorders such as anxiety and epilepsy.